Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peritonsillar bupivacaine versus lignocaine versus saline for post-tonsillectomy pain in children
PACTR202408714414101Phase 3Not yet recruiting
- Sponsor
- Fadhili Samsoni
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial comparing Bupivacaine peritonsillar infiltration, Lignocaine peritonsillar infiltration and Saline peritonsillar infiltration (3 arms). Primary endpoint: Pain scores. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
bupivacainelidocainesaline
Beyond the preview
Go deeper on PACTR202408714414101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202408714414101.